{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:15:17Z","timestamp":1717287317006},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"DOI":"10.7759\/cureus.61479","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:11:43Z","timestamp":1717233103000},"source":"Crossref","is-referenced-by-count":0,"title":["Changes in Renal Function After Nephroureterectomy for Upper Tract Urothelial Cancer in Elderly Patients"],"prefix":"10.7759","author":[{"given":"Tatsuya","family":"Kawamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Ikarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arisa","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigekatsu","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renpei","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsugu","family":"Kanehira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat M","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, et al.. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol. 2023, 84:49-64. 10.1016\/j.eururo.2023.03.013","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle A","year":"2020","unstructured":"Birtle A, Johnson M, Chester J, et al.. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020, 395:1268-77. 10.1016\/S0140-6736(20)30415-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin DF","year":"2021","unstructured":"Bajorin DF, Witjes JA, Gschwend JE, et al.. Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma. N Engl J Med. 2021, 384:2102-14. 10.1056\/NEJMoa2034442","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023, 73:17-48. 10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.029","article-title":"Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy","volume":"58","author":"Kaag MG","year":"2010","unstructured":"Kaag MG, O'Malley RL, O'Malley P, et al.. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol. 2010, 58:581-7. 10.1016\/j.eururo.2010.06.029","journal-title":"Eur Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo S","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al.. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009, 53:982-92. 10.1053\/j.ajkd.2008.12.034","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.4924","article-title":"Randomized phase II\/III trial assessing gemcitabine\/ carboplatin and methotrexate\/carboplatin\/vinblastine in patients with advanced urothelial cancer \"unfit\" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986","volume":"27","author":"De Santis M","year":"2009","unstructured":"De Santis M, Bellmunt J, Mead G, et al.. Randomized phase II\/III trial assessing gemcitabine\/ carboplatin and methotrexate\/carboplatin\/vinblastine in patients with advanced urothelial cancer \"unfit\" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986. J Clin Oncol. 2009, 27:5634-9. 10.1200\/JCO.2008.21.4924","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-04156-3","article-title":"Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)","volume":"40","author":"Tafuri A","year":"2022","unstructured":"Tafuri A, Marchioni M, Cerrato C, et al.. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium). World J Urol. 2022, 40:2771-9. 10.1007\/s00345-022-04156-3","journal-title":"World J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyv136","article-title":"Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma","volume":"45","author":"Hashimoto T","year":"2015","unstructured":"Hashimoto T, Ohno Y, Nakashima J, et al.. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma. Jpn J Clin Oncol. 2015, 45:1064-8. 10.1093\/jjco\/hyv136","journal-title":"Jpn J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11649.x","article-title":"Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy","volume":"112","author":"Xylinas E","year":"2013","unstructured":"Xylinas E, Rink M, Margulis V, et al.. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int. 2013, 112:453-61. 10.1111\/j.1464-410X.2012.11649.x","journal-title":"BJU Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urols.2014.07.001","article-title":"Longitudinal change in renal function after nephroureterectomy in patients with upper tract urothelial carcinoma","volume":"26","author":"Chou C","year":"2015","unstructured":"Chou C, Chuang C, Chang Y, Yu KJ, Lin PH, Pang ST. Longitudinal change in renal function after nephroureterectomy in patients with upper tract urothelial carcinoma. Urol Sci. 2015, 26:115-9. 10.1016\/j.urols.2014.07.001","journal-title":"Urol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2022.04.007","article-title":"Survival and long-term effect of kidney-sparing surgery versus radical nephroureterectomy on kidney function in patients with upper urinary tract urothelial carcinoma","volume":"40","author":"Hendriks N","year":"2022","unstructured":"Hendriks N, Baard J, Beerlage HP, Schout BM, Doherty KS, Pelger RC, Kamphuis GM. Survival and long-term effect of kidney-sparing surgery versus radical nephroureterectomy on kidney function in patients with upper urinary tract urothelial carcinoma. Eur Urol Open Sci. 2022, 40:104-11. 10.1016\/j.euros.2022.04.007","journal-title":"Eur Urol Open Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3277-x","article-title":"The impact of a solitary kidney on tolerability to gemcitabine plus cisplatin chemotherapy in urothelial carcinoma patients: a retrospective study","volume":"79","author":"Kondo M","year":"2017","unstructured":"Kondo M, Hotta Y, Ando R, Yasui T, Kimura K. The impact of a solitary kidney on tolerability to gemcitabine plus cisplatin chemotherapy in urothelial carcinoma patients: a retrospective study. Cancer Chemother Pharmacol. 2017, 79:995-1001. 10.1007\/s00280-017-3277-x","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/end.2014.0277","article-title":"The significance of functional renal obstruction in predicting pathologic stage of upper tract urothelial carcinoma","volume":"28","author":"Amirian MJ","year":"2014","unstructured":"Amirian MJ, Radadia K, Narins H, et al.. The significance of functional renal obstruction in predicting pathologic stage of upper tract urothelial carcinoma. J Endourol. 2014, 28:1379-83. 10.1089\/end.2014.0277","journal-title":"J Endourol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis V","year":"2020","unstructured":"Margulis V, Puligandla M, Trabulsi EJ, et al.. Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma. J Urol. 2020, 203:690-8. 10.1097\/JU.0000000000000644","journal-title":"J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyac155","article-title":"Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial","volume":"53","author":"Tomita Y","year":"2023","unstructured":"Tomita Y, Kobayashi K, Kimura G, et al.. Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial. Jpn J Clin Oncol. 2023, 53:16-25. 10.1093\/jjco\/hyac155","journal-title":"Jpn J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253606-changes-in-renal-function-after-nephroureterectomy-for-upper-tract-urothelial-cancer-in-elderly-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:11:46Z","timestamp":1717233106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253606-changes-in-renal-function-after-nephroureterectomy-for-upper-tract-urothelial-cancer-in-elderly-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.61479","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}